TAKEDA PHARMACEUTICAL CO LTDTAK決算レポート
NYSE · pharmaceutical industry
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived th...
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| BlackRock, Inc. | 7.70% | 121.2M | — | 2024-02-06 |
| Sumitomo Mitsui Trust Holdings, Inc. | 5.50% | 87.4M | — | 2024-02-05 |
インサイダー取引
Net 90d: +$0 · buys $0 / sells $0期間:
種別:
役職:
条件に一致する取引はありません。